The Indian pharma sector is expected to benefit from the Biden
presidency on the back of an increased push for generic prescriptions
and access to affordable health insurance.
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/bidencare-a-boost-for-indian-pharmaceutical-companies/articleshow/79122950.cms
Sunday, November 8, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment